Licensed drug makers get relief on exports
Mumbai: In a bid to ensure ease of doing business and facilitate exports, the health ministry has relaxed guidelines for pharmaceutical and medical device manufacturers. Licensed manufacturers of drugs, medical…
Bayer gets European Commission nod for Monsanto deal
New Delhi: German chemical and pharma major Bayer today said it has received “conditional” approval from the European Commission for its proposed USD 66 billion acquisition of US-based biotech major…
Genetic disorders to hike health premiums?
Mumbai: Insurance companies say that they might need to go to the regulator and seek higher premiums if inclusion of genetic disorders increases their claims outgo. On Monday, the Insurance…
IBM predicts embedding tiny chips in products to check counterfeit
Las Vegas: Tech Giant IBM on Tuesday predicted that within the next five years, cryptographic anchors such as ink dots, or tiny computers smaller than a grain of salt, will…
As assisted births rise, hospitals scale up infrastructure
BENGALURU: There has been a surge in demand for assisted reproductive technology (ART), including in-vitro fertilization (IVF), as lifestyle changes increase infertility rates and as more Indians shed their inhibitions…
Alembic Pharma gets 3 observations from USFDA for Gujarat plant
New Delhi: Alembic Pharmaceuticals today said the US health regulator has made three observations after inspecting its formulation facility in Panelav, Gujarat. “The United States Food and Drug Administration (USFDA)…
‘Make in India’ slogan a mere charade for Indian Medical Device Manufacturers
New Delhi: ‘Make in India’ slogan has proved a song without lyrics for Indian Medical device manufacturers. The Draft Medical Devices Preferential Market Access Policy issued by Department of Pharmaceuticals…
‘No action in executive kidney transplant case’
A day after it emerged that the request of a top executive of a leading telecom firm for kidney transplant was turned down, the state organ transplant officer said that…
Weight loss therapy leaves woman with brain disorder
A naturopathy-based weight loss programme, popular across a cross-section of society these days, has gone horribly wrong for Gauri Atre, such that the 33-year-old Nanded woman is now left with…
We have niche strategy in US, leadership strategy in Australia: Shashank Sinha, Strides Shasun
In an interview with ET Now, Shashank Sinha, Strides Shasun, says their US portfolio is going to ramp up significantly and would probably double or nearly double in the next…
